Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06537115
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-28
Brief Title:
Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopeniaa RCT Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial is a multicenter single-blind prospective randomized controlled clinical application study Subjects who met the trial criteria and signed the informed consent form were randomly divided into a control group an experimental group 1 and an experimental group 2 After enrollment the control group underwent a comprehensive assessment of their underlying conditions by professional physicians and received routine interventions including basic nutritional intervention program guidance progressive resistance exercise intervention program guidance safety precautions and symptomatic treatment for different complications for a total intervention period of 24 weeks The experimental group 1 in addition to the interventions provided to the control group received whey protein powder supplementation for 12 weeks The experimental group 2 on the other hand received both whey protein powder and eldecalcitol supplementation on top of the interventions given to the control group also for 12 weeks The entire intervention period lasted for 24 weeks Through regular general assessments blood tests measurements of muscle mass muscle strength and physical function as well as analyses of negative adverse events statistical methods were employed to evaluate the safety and efficacy of the comprehensive intervention methods for sarcopenia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None